Nisa Investment Advisors
TVTX icon

Nisa Investment Advisors’s Travere Therapeutics TVTX Stock Holding History

Nisa Investment Advisors’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$147K Buy
4,947
+915
+23% +$27.4K ﹤0.01% 1306
2025
Q4 		$154K Sell
4,032
-124
-3% -$4.03K ﹤0.01% 1294
2025
Q3 		$99.3K Hold
4,156
– – ﹤0.01% 1437
2025
Q2 		$61.5K Sell
4,156
-93
-2% -$1.54K ﹤0.01% 1543
2025
Q1 		$76.1K Sell
4,249
-636
-13% -$12.9K ﹤0.01% 1469
2024
Q4 		$85.1K Buy
4,885
+39
+0.8% +$690 ﹤0.01% 1517
2024
Q3 		$67.8K Sell
4,846
-930
-16% -$9.69K ﹤0.01% 1555
2024
Q2 		$47.5K Buy
5,776
+41
+0.7% +$276 ﹤0.01% 1686
2024
Q1 		$44.2K Buy
5,735
+85
+2% +$717 ﹤0.01% 1689
2023
Q4 		$50.8K Buy
5,650
+5,121
+968% +$37.3K ﹤0.01% 1633
2023
Q3 		$4.73K Sell
529
-3,652
-87% -$51.5K ﹤0.01% 2290
2023
Q2 		$64.2K Buy
4,181
+1,657
+66% +$30.1K ﹤0.01% 1662
2023
Q1 		$57K Buy
2,524
+24
+1% +$510 ﹤0.01% 1676
2022
Q4 		$53K Sell
2,500
-49
-2% -$1.04K ﹤0.01% 1747
2022
Q3 		$63K Buy
2,549
+49
+2% +$1.27K ﹤0.01% 1660
2022
Q2 		$61K Sell
2,500
-2,170
-46% -$54.6K ﹤0.01% 1672
2022
Q1 		$120K Sell
4,670
-190
-4% -$5.04K ﹤0.01% 1560
2021
Q4 		$134K Buy
4,860
+1,640
+51% +$46.2K ﹤0.01% 1406
2021
Q3 		$78 Buy
3,220
+1,000
+45% +$18.4K ﹤0.01% 1805
2021
Q2 		$32 Sell
2,220
-5,400
-71% -$107K ﹤0.01% 2039
2021
Q1 		$190 Hold
7,620
– – ﹤0.01% 1509
2020
Q4 		$208K Buy
7,620
+3,250
+74% +$75.9K ﹤0.01% 1453
2020
Q3 		$81K Buy
4,370
+2,400
+122% +$46.6K ﹤0.01% 1608
2020
Q2 		$40K Hold
1,970
– – ﹤0.01% 1630
2020
Q1 		$29K Buy
1,970
+1,000
+103% +$15K ﹤0.01% 1643
2019
Q4 		$14K Buy
970
+500
+106% +$6.39K ﹤0.01% 1767
2019
Q3 		$5K Buy
470
+200
+74% +$3.31K ﹤0.01% 1907
2019
Q2 		$5K Hold
270
– – ﹤0.01% 1900
2019
Q1 		$6K Hold
270
– – ﹤0.01% 1880
2018
Q4 		$6K Hold
270
– – ﹤0.01% 1780
2018
Q3 		$8K Sell
270
-30
-10% -$858 ﹤0.01% 1791
2018
Q2 		$8K Hold
300
– – ﹤0.01% 1783
2018
Q1 		$7K Sell
300
-300
-50% -$7.14K ﹤0.01% 1744
2017
Q4 		$13K Hold
600
– – ﹤0.01% 1682
2017
Q3 		$15K Hold
600
– – ﹤0.01% 1618
2017
Q2 		$12K Sell
600
-3,720
-86% -$67.5K ﹤0.01% 1664
2017
Q1 		$80K Buy
4,320
+3,720
+620% +$72.8K ﹤0.01% 1389
2016
Q4 		$11K Buy
+600
New +$12.3K ﹤0.01% 1789

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nisa Investment Advisors's TVTX Position: Q1 2026 in Review

Nisa Investment Advisors increased its Travere Therapeutics (TVTX) stake by 23% in Q1 2026, buying an estimated $27.4K and bringing the position to 4,947 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #1306.

Nisa Investment Advisors first reported a position in TVTX in Q4 2016 and has held it in 38 quarters since. The position peaked at $208K in Q4 2020. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Nisa Investment Advisors held 4,947 shares of Travere Therapeutics worth $147K as of Q1 2026.
  • Nisa Investment Advisors bought 915 Travere Therapeutics shares in Q1 2026, an estimated $27.4K.
  • Travere Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1306 holding.
  • Nisa Investment Advisors first reported a position in Travere Therapeutics in Q4 2016 and has held it in 38 quarters since.
  • Nisa Investment Advisors's Travere Therapeutics position peaked at $208K in Q4 2020.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.